{"product_id":"bravecto-1400mg-1-tableta-masticabila-40-56kg-purici-capuse","title":"BRAVECTO 1400mg, 1 tableta 40-56kg","description":"\u003ch4\u003e INDICATII BRAVECTO\u003c\/h4\u003e\n\u003cp\u003eeficient timp de 12 saptamani\u003c\/p\u003e\n\u003cp\u003e- activitatea de ucidere imediata si persistenta pentru capuse timp de 12 saptamani pentru Ixodes ricinus, Dermacentor reticulatus si D. variabilis\u003c\/p\u003e\n\u003cp\u003e- activitatea de ucidere imediata si persistenta pentru capuse timp de 8 saptamani pentru Rhiphicephalus sanguineus.\u003c\/p\u003e\n\u003cp\u003ePuricii si capusele trebuie sa fie atasate la gazda si sa se hraneasca  cu scopul de a fi expuse la substanta activa. Debutul efectului este la 8 ore dupa fixare  pentru purici (C. felis) si 12 de ore dupa atasare pentru capuse (I. ricinus).\u003c\/p\u003e\n\u003cp\u003eProdusul se poate utiliza ca parte a strategiei de tratament pentru controlul dermatitei alergice produse de purici (DAP).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATII\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNu se utilizeaza in caz de hipersensibilitate la substanta activa sau la oricare dintre excipienti.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eREACTII ADVERSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eReactiile adverse comune observate in testele clinice (1.6% din cainii tratati) au fost efecte gastrointestinale usoare si tranzitorii precum diareea, voma, inapetenta si salivatie.\u003c\/p\u003e\n\u003cp\u003eFrecventa reactiilor adverse este definita utilizand urmatoarea conventie:\u003c\/p\u003e\n\u003cp\u003e- foarte frecvente (mai mult de 1 din 10 animale care prezinta reactii adverse in timpul unui tratament)\u003c\/p\u003e\n\u003cp\u003e- frecvente (mai mult de 1, dar mai putin de 10 din 100 de animale)\u003c\/p\u003e\n\u003cp\u003e- mai putin frecvente (mai mult de 1, dar mai putin de 10 animale din 1.000 de animale)\u003c\/p\u003e\n\u003cp\u003e- rare (mai mult de 1, dar mai putin de 10 animale din 10.000 animale)\u003c\/p\u003e\n\u003cp\u003e- foarte rare (mai putin de 1 animal din 10.000 de animale, inclusiv rapoarte izolate)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eDaca observati reactii grave sau alte efecte care nu sunt mentionate in acest prospect, va rugam informati medicul veterinar.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMINISTRARE:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTablete masticabile nu trebuie rupte sau divizate.\u003c\/p\u003e\n\u003cp\u003eBravecto comprimate masticabile se administreaza la sau in jur de orei de hranire.\u003c\/p\u003e\n\u003cp\u003eBravecto este un comprimat masticabil si este bine acceptat de majoritatea cainilor. Daca tableta nu este preluata  in mod voluntar de caine poate fi, de asemenea, administrat cu alimente sau direct in cavitatea bucala. Cainele trebuie sa fie observat in timpul administrarii pentru a se confirma faptul ca tableta este inghitita.\u003c\/p\u003e\n\u003cp\u003eSchema de tratament:\u003c\/p\u003e\n\u003cp\u003ePentru un control optim al infestarii cu purici, produsul medicinal veterinar poate fi administrat la intervale de 12 saptamani. Pentru un control optim al infestarii cu capuse, momentul readministrarii depinde de specia de capuse.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eATENTIONARI SPECIALE:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtentionari speciale pentru fiecare specie tinta:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePentru a fi expusi la fluralaner este necesar ca parazitii sa inceapa hranirea pe gazda; prin urmare riscul de raspandire al bolilor transmisibile nu se poate exclude.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautii speciale pentru utilizare la animale:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn absenta datelor disponibile, produsul medicinal vaterinar nu trebuie utilizat la catei mai tineri de 8 saptamani sau\/si cu greutatea mai mica de 2 kg.\u003c\/p\u003e\n\u003cp\u003eProdusul nu trebuie administrat la intervale mai mici de 8 saptamani deoarece siguranta pentru intervale mai scurte nu a fost testata.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautii speciale care trebuie luate de persoana care administreaza produsul medicinal veterinar la animale\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA se pastra produsul in ambalajul original pana la utilizare pentru a preveni accesul direct al copiilor la produs.\u003c\/p\u003e\n\u003cp\u003eNu se mananca, bea sau fumeaza in timpul manipularii produsului.\u003c\/p\u003e\n\u003cp\u003eA se spala bine mainile cu apa si sapun dupa utilizarea produsului.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUtilizare in perioada de gestatie, lactatie sau in perioada de ouat \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSiguranta produsului medicinal veterinar a fost stabilita pe durata cresterii,gestatiei lactatiei. se poate utiliza la animalele de reproductie, la femelele gestante si in lactatie.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInteractiuni cu alte produse medicinale sau alte forme de interactiune\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNu se cunosc.\u003c\/p\u003e\n\u003cp\u003eFluralaner se leaga de proteinele plasmatice si poate concura cu alte medicamente cu nivel crescut de legare, cum ar fi medicamente anti-inflamatoare nesteroidiene (AINS) si derivatul cumarinic varfarina. Incubarea fluralaner in prezenta carprofenului sau a varfarinei in plasma la caine la concentratii plasmatice maxime preconizate nu a redus legarea de proteine a fluralaner, carprofenului sau varfarinei.\u003c\/p\u003e\n\u003cp\u003ePe perioada testelor clinice, nu au aparut interactiuni intre Bravecto tablete masticabile pentru caini si produsele medicinale veterinare de rutina  utilizate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSupradozare\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNu au fost observate reactii adverse in urma administrarii orale la pui de 8–9 saptamani si greutate de 2.0–3.6 kg tratati cu supradoze de pana la 5 ori doza maxima recomandata (56 mg, 168 mg si 280 mg fluralaner \/ kg greutate corporala) la intervale mai scurte de trei ori decat cele recomandate (intervale de 8 saptamani).\u003c\/p\u003e\n\u003cp\u003eNu s-a concluzionat asupra performantelor reproductive si nici rezultatele de interes asupra viabilitatii puilor dupa ce fluralaner a fost administrat pe cale orala la cainii Beagle cu supradoze de pana la 3 ori doza maxima recomandata (de pana la 168 mg \/ kg de fluralaner).\u003c\/p\u003e\n\u003cp\u003eAcest produs medicinal veterinar a fost bine tolerat la Collie cu un deficit de Rezistenta la medicamente a proteinelor-1 (MDR1 -\/-) dupa administrarea orala unica a dozei de 3 ori doza recomandata (168 mg \/ kg). Nu au fost observate semne clinice legate de tratament.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIncompatibilitati\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNu se cunosc.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMINISTRARE:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePentru administrare orala.\u003c\/p\u003e\n\u003cp\u003eBravecto trebuie administrat in concordanta cu urmatorul tabel (corespunzator cu doza de 25.56 fluralaner\/kg greutate corporala corespunzator cu banda de greutate corporala):\u003c\/p\u003e\n\u003ctable border=\"1\" cellspacing=\"1\" cellpadding=\"1\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd rowspan=\"2\" scope=\"col\"\u003eGreutate corporala a cainelui (kg)\u003c\/td\u003e\n\u003ctd colspan=\"5\" scope=\"row\"\u003eConcentratia si numarul de tablete care trebuiesc administrate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBravecto 112.5 mg\u003c\/td\u003e\n\u003ctd\u003eBravecto 250 mg\u003c\/td\u003e\n\u003ctd\u003eBravecto 500 mg\u003c\/td\u003e\n\u003ctd\u003eBravecto 1000 mg\u003c\/td\u003e\n\u003ctd\u003eBravecto 1400 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e    2-4.5\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e    \u0026gt;4.5-10\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e    \u0026gt;10-20\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e    \u0026gt;20-40\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd rowspan=\"1\"\u003e    \u0026gt;40-56\u003c\/td\u003e\n\u003ctd rowspan=\"1\"\u003e\u003c\/td\u003e\n\u003ctd rowspan=\"1\"\u003e\u003c\/td\u003e\n\u003ctd rowspan=\"1\"\u003e\u003c\/td\u003e\n\u003ctd rowspan=\"1\"\u003e\u003c\/td\u003e\n\u003ctd rowspan=\"1\"\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003ePentru caini peste 56 kg greutate corporala, utilizati o combinatie de doua comprimate care se potriveste cel mai bine cu greutatea animalului.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eATENTIE:\u003c\/strong\u003e Se elibereaza doar pe baza de prescriptie medicala.\u003c\/p\u003e\n\u003cp\u003e[\/read]\u003c\/p\u003e\n","brand":"MSD Animal Health","offers":[{"title":"Default Title","offer_id":52806179914070,"sku":"gla_3591","price":188.0,"currency_code":"RON","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1008\/4850\/1078\/files\/3591_bravecto_40-56_kg.jpg?v=1773325508","url":"https:\/\/adavet.ro\/products\/bravecto-1400mg-1-tableta-masticabila-40-56kg-purici-capuse","provider":"Adavet","version":"1.0","type":"link"}